Stock markets will break out of current stagnation and continue the rally, analysts say
Trader on the floor of the New York Stock Exchange.
LONDON — Global stock markets have stagnated in recent weeks despite a deluge of strong earnings and economic data, but analysts think the rally will regain momentum.
The current round of corporate earnings is proving to be one of the most successful in history with more than a third of blue chip companies having reported so far, Barclays analysts noted on Thursday. Earnings per share growth has vastly exceeded expectations in the U.S. and Europe and the proportion of earnings beats is close to a historical high.
However, analysts have suggested that high expectations have largely been priced in, meaning the share price reaction thus far has skewed slightly to the downside.
A spike in inflation has also been cited as underlying some investor reticence toward risk assets, with concerns persisting that central banks will begin scaling back their unprecedented monetary stimulus.
Inflation spike not the end of the rally
The latest inflation readings out of the U.S. and Europe have risen sharply, and UBS strategists anticipate that this will continue over the coming months with signs of price pressures enduring.
However, in a note to investors Thursday, they attributed this to base effects and short-term supply constraints, rather than structural issues.
UBS Global Wealth Management Chief Investment Officer Mark Haefele said this indicated that the spike in inflation will likely be transitory and should be seen as a potential source of volatility, rather than a long-term threat to the overall equity market rally.
“With economies still running below potential output, we don’t currently forecast a sustained rise in inflation that would compel central banks to tighten monetary conditions,” Haefele said.
U.S. Federal Reserve Chairman Jerome Powell alluded to this following the central bank’s monetary policy meeting on Wednesday. The Fed expects the current spurt of inflation to be transitory and still sees considerable slack in the labor market, meaning policy is unlikely to be tightened in the immediate future.
Haefele suggested that the Fed actually wants inflation to overshoot its 2% target in order to offset a long-standing undershoot in recent years.
He also highlighted that profit margins do not seem to be at risk due to the temporary rise in costs.
“While input prices have risen for many companies, we do not expect this to be a significant headwind for earnings,” Haefele said.
“In an environment of strong consumer demand, we expect revenue growth to help offset the drag from input costs,”
While a transient inflation spike may cause some investor jitters that leads to increased volatility, UBS anticipates that equity markets can continue to climb, favoring cyclical stocks — those whose performance tends to align with macroeconomic conditions — as the global recovery broadens out.
Vulnerable to shocks
Barclays highlighted that mutual fund buying has slowed from its record pace in the first quarter, while trading volumes and retail participation in stock markets have tailed off significantly, with cash being spent in the economy as it opens up.
The British lender has previously flagged that unfavorable technicals and seasonal trading trends could mean the market is at risk of a pullback, should a substantial negative catalyst arise.
Although the market is more vulnerable to bad news, Barclays Head of European Equity Strategy Emmannuel Cau believes investors will continue to buy dips given the strong earnings, abundant liquidity and high level of holdings in bonds and cash at present.
The S&P 500 opened at record highs on Thursday on the back of blowout earnings, having struggled for direction over the past two weeks following a rally of more than 12 months since the recent lows of the March 2020 coronavirus crash.
However, he argued that with the reflation trade stalling, value stocks — companies whose shares are cheap relative to their fundamentals — offer better risk-reward than cyclicals.
“While Cyclicals are supported by strong earnings, we think valuations and positioning are now less favorable, which calls for a more balanced allocation vs. the less exciting but cheaper Defensives,” Cau said in a note to investors Wednesday.
“We continue to see Value offering an attractive hedge against higher inflation and rising yields, while it could also catch a bid from momentum strategies.”
David Marchant, CIO of Canada Life Asset Management, told CNBC on Thursday that the market may be underestimating the scale of the economic recovery and its potential impact on corporate earnings, given that companies have cut costs during the pandemic but will now begin to see sales start to rise. However, he echoed Barclays’ call for investors to hedge against downside risks.
“Whilst I still think given where we are, given the ongoing support for markets from monetary policy, equities will probably stay up and may continue to drift higher, but I just think you need to exercise a degree of caution, be a little more selective about where you are putting your money,” he said.
- Amcham finds 42% of members surveyed are planning or considering leaving Hong Kong
- Tuchel: I lied to Auba about meeting times
- ‘You breathe differently when you aren’t the only one:’ Women are leading America’s key news outlets
- Police: Babies abducted during Savannah shooting found safe, suspect now in custody
- Greg Gutfeld: Despite statistics showing low outdoor COVID spread, media peddles fear
- Liz Cheney shames colleagues who will purge her for disloyalty to Trump
- Favre yet to repay state $600K, Mississippi says
- One in four cities cannot afford climate crisis protection measures – study
- This Day in History: May 12
- British troops were twice as likely to be killed in Afghanistan as US forces
Common Symptoms Of COVID-19
The CDC has a collection of nine Roche antibody assays designed to provide rapid results from COVID-19 rapid antigen test. If you are a potential carrier of the human papilloma virus (HPV) and are looking for HPV testing kits for the home, it is important…
Things You Never Knew About The Best Water Purifier
Things You Never Knew About The Best Water Purifier: We all know the importance of having a water purifier at home, but not many people know the things they need to know before buying one. Most of the time, we miss out on the most…
Med hub smart pill, a device for patients having medicines intake in the daily schedule.
Med hub smart pill: The drug prescribed by a doctor will be effective if it would be taken at the right time suggested by the doctor because it is necessary for our healing process. When a patient takes too many medicians in a day also…
10 Best Effective Plants to Fight Pollution – Diwali Edition
Effective Plants to Fight Pollution: Few more months and the most awaited festival of the year will be here. We Indians love our festivals, and the biggest festival of India, especially north India, is Diwali. It is a massive affair here. It generally falls in…